Papers
5
Total Citations
31
H-Index
3
About
Dr. Ryo Minoda is a pioneering urologic surgeon whose research centers on advancing minimally invasive robotic surgery for complex renal and prostate cancers. His major contributions lie in refining surgical techniques to maximize organ preservation and expand treatment options for patients with anatomically challenging tumors. In a landmark 2021 study, Dr. Minoda demonstrated through a 1:1 propensity score-matched analysis that enucleation during robot-assisted partial nephrectomy (RAPN) yields superior renal parenchymal preservation compared to standard resection for completely endophytic renal tumors, a finding that has garnered 16 citations and influenced surgical practice. He has further pushed boundaries by reporting the first successful use of preoperative lenvatinib and pembrolizumab combination therapy for advanced renal cell carcinoma with inferior vena cava thrombus (2024, 5 citations), showcasing his integration of cutting-edge systemic therapies with surgery. Dr. Minoda has also documented the effectiveness of Retzius-sparing robot-assisted radical prostatectomy in renal transplant recipients (2022, 5 citations) and performed RAPN with selective artery clamping for renal cell carcinoma in horseshoe kidneys (2024, 3 citations), addressing rare, high-complexity cases. His work on combined pembrolizumab and pelvic radiotherapy for bladder cancer with rectal metastases (2023, 2 citations) further underscores his commitment to multimodal, organ-sparing approaches. Through these innovations, Dr. Minoda is redefining the surgical management of urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5